Proton pump inhibitors: A survey of prescribing in an Irish general hospital

International Journal of Clinical Practice

Volumn 59, Issue 1, 2005, Pages 31-34

  Mat Saad, A Z ^a   Collins, N ^a   Lobo, M M ^a   O'Connor, Humphrey J ^a,b  

^a Tullamore General Hospital   (Ireland)

^b ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ESOMEPRAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANTOPRAZOLE; PREDNISOLONE; PROTON PUMP INHIBITOR; RABEPRAZOLE; WARFARIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DYSPEPSIA; FEMALE; GASTROESOPHAGEAL REFLUX; GENERAL HOSPITAL; HEALTH SURVEY; HUMAN; IRELAND; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRESCRIPTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT INDICATION;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; AGED, 80 AND OVER; ANTI-ULCER AGENTS; BENZIMIDAZOLES; FEMALE; HEALTH SURVEYS; HOSPITALIZATION; HOSPITALS, GENERAL; HUMANS; IRELAND; MALE; MEDICAL AUDIT; MIDDLE AGED; OMEPRAZOLE; PHYSICIAN'S PRACTICE PATTERNS; PROTON PUMPS;

EID: 13844319580     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2004.00298.x     Document Type: Article

References (21)

1. Barrison AF, Jarboe LA, Weinberg BM et al. Patterns of proton pump inhibitor use in clinical practice. Am J Med 2001; 111: 469-73.
2. Booth EH, Blenkinsopp A. The rise and rise of proton pump inhibitor drugs: patients' perspectives. Soc Sci Med 1997; 45 1571-9.
3. Cooper AL, Longworthy H, Porter S. Cost-effective prescribing of proton pump inhibitor therapy: an audit in general practice. Int J Clin Pract 2000; 54: 287-92.
4. Monthly Index of Medical Specialities, Dublin, Ireland: Medical Publications May 2001; 5-6.
5. Williams M, Pounder RE. An audit of proton pump inhibitor usage in a teaching hospital setting. Gut 1997; 40: A59.
6. Sebastian SS, Kernan N, Qasim A, O'Morain CA, Buckley MB. Appropriateness of gastric antisecretory therapy in hospital practice. Ir J Med Sci 2003; 172: 115-7.
7. Pillans PI, Kubler PA, Radford JM, Overland V. Concordance between use of proton pump inhibitors and prescribing guidelines. Med J Aust 2000; 172: 16-8.
8. Newton M, Smith G, Burnham WR et al. Hospital use of proton pump inhibitors: a completed audit of the introduction of a prescribing protocol on inpatient prescription. Gastroenterology 1998; 114 A30.
9. Naunton M, Peterson GM, Bleasel MD. Overuse of proton pump inhibitors. J Clin Pharm Ther 2000; 25: 333-40.
10. Walker NM, McDonald J. An evaluation of the use of proton pump inhibitors. Pharm World Sci 2001; 23: 116-7.
11. Pohland CJ, Scavnicky SA, Lasky SS, Good CB. Lansoprazole overutilization: methods for step-down therapy. Am J Manag Care 2003; 9: 353-8.
12. Parente F, Cucino C, Gallus S et al. Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: a 1-month survey. Aliment Pharmacol Ther 2003; 17: 1503-6.
13. Brandhagen DJ, Pheley AM, Onstad GR, Freeman ML, Lurie N. Omeprazole use at an urban county teaching hospital. J Gen Intern Med 1995; 10: 513-5.
14. Bashford JN, Norwood J, Chapman SR Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database. BMJ 1998; 317: 452-6.
15. Bramble MG, Suvakovic Z, Hungin APS. Detection of upper gastrointestinal cancer in patients taking antisecretory therapy prior to gastroscopy. Gut 2000; 46: 464-7.
16. Pitkala KH, Strandberg TE, Tilvio RS. Is it possible to reduce polypharmacy in the elderly. Drugs Aging 2001; 18: 143-9.
17. Cunney A, Williams D, Feely J. Prescription monitoring in an Irish hospital. Ir Med J 2003; 96: 20-3.
18. Hawkey CJ, Hodgson S, Norman A, Daneshmend TK, Garner ST. Effect of reactive pharmacy intervention on quality of hospital prescribing. BMJ 1990; 300: 986-90.
19. Kumana CR, Ching T-Y, Cheung E et al. Antiulcer drug prescribing in hospital successfully influenced by "immediate con-current feedback". Clin Pharmacol Ther 1998; 64: 569-74.
20. Valori RM, Brown CM, Strangeways P, Bradburn M. Reducing community dyspepsia drug costs: a controlled trial. Gut 2001; 49 495-501.
21. Pollock K, Grime J. Strategies for reducing the prescribing of proton pump inhibitors (PPIs): patient self-regulation of treatment may be an under-exploited resource. Soc Sci Med 2000; 51: 1827-39.